Dendrimeric nanosystem consistently circumvents heterogeneous drug response and resistance in pancreatic cancer
Pancreatic ductal adenocarcinoma (PDAC) is a deadly cancer with no efficacious treatment.
The application of nanomedicine is expected to bring new hope to PDAC treatment. In this …
The application of nanomedicine is expected to bring new hope to PDAC treatment. In this …
[PDF][PDF] Dendrimeric nanosystem consistently circumvents heterogeneous drug response and resistance in pancreatic cancer
J Liu, C Chen, T Wei, O Gayet, C Loncle, L Borge… - 2021 - researchgate.net
Pancreatic ductal adenocarcinoma (PDAC) is a deadly cancer with no efficacious treatment.
The application of nanomedicine is expected to bring new hope to PDAC treatment. In this …
The application of nanomedicine is expected to bring new hope to PDAC treatment. In this …
[引用][C] Dendrimeric Nanosystem Consistently Circumvents Heterogeneous Drug Response and Resistance in Pancreatic Cancer
J Liu, C Chen, T Wei, O Gayet, C Loncle… - Energy Exploration …, 2021 - amu.hal.science
Dendrimeric Nanosystem Consistently Circumvents Heterogeneous Drug Response and
Resistance in Pancreatic Cancer - Aix-Marseille Université Accéder directement au contenu …
Resistance in Pancreatic Cancer - Aix-Marseille Université Accéder directement au contenu …
[HTML][HTML] Dendrimeric nanosystem consistently circumvents heterogeneous drug response and resistance in pancreatic cancer
J Liu, C Chen, T Wei, O Gayet, C Loncle, L Borge… - Exploration, 2021 - ncbi.nlm.nih.gov
Pancreatic ductal adenocarcinoma (PDAC) is a deadly cancer with no efficacious treatment.
The application of nanomedicine is expected to bring new hope to PDAC treatment. In this …
The application of nanomedicine is expected to bring new hope to PDAC treatment. In this …
[引用][C] Dendrimeric Nanosystem Consistently Circumvents Heterogeneous Drug Response and Resistance in Pancreatic Cancer
J Liu, C Chen, T Wei, O Gayet, C Loncle… - Energy Exploration and …, 2021 - hal.science
Dendrimeric Nanosystem Consistently Circumvents Heterogeneous Drug Response and
Resistance in Pancreatic Cancer - Archive ouverte HAL Accéder directement au contenu …
Resistance in Pancreatic Cancer - Archive ouverte HAL Accéder directement au contenu …
Dendrimeric nanosystem consistently circumvents heterogeneous drug response and resistance in pancreatic cancer
J Liu, C Chen, T Wei, O Gayet… - Exploration …, 2021 - pubmed.ncbi.nlm.nih.gov
Pancreatic ductal adenocarcinoma (PDAC) is a deadly cancer with no efficacious treatment.
The application of nanomedicine is expected to bring new hope to PDAC treatment. In this …
The application of nanomedicine is expected to bring new hope to PDAC treatment. In this …
[PDF][PDF] Dendrimeric nanosystem consistently circumvents heterogeneous drug response and resistance in pancreatic cancer
J Liu, C Chen, T Wei, O Gayet, C Loncle, L Borge… - 2021 - scholar.archive.org
Pancreatic ductal adenocarcinoma (PDAC) is a deadly cancer with no efficacious treatment.
The application of nanomedicine is expected to bring new hope to PDAC treatment. In this …
The application of nanomedicine is expected to bring new hope to PDAC treatment. In this …
[引用][C] Back Cover: Dendrimeric nanosystem consistently circumvents heterogeneous drug response and resistance in pancreatic cancer (EXP2 1/2021)
J Liu, C Chen, T Wei, O Gayet, C Loncle, L Borge… - …, 2021 - Wiley Online Library
A fluorinated amphiphilic dendrimer based nanosystem to combat PDAC is reported by Juan
Liu and co-workers in the article number 20210003. These nanoparticles markedly …
Liu and co-workers in the article number 20210003. These nanoparticles markedly …
Dendrimeric nanosystem consistently circumvents heterogeneous drug response and resistance in pancreatic cancer
J Liu, C Chen, T Wei, O Gayet, C Loncle, L Borge… - EXPLORATION, 2021 - arts.units.it
Pancreatic ductal adenocarcinoma (PDAC) is a deadly cancer with no efficacious treatment.
The application of nanomedicine is expected to bring new hope to PDAC treatment. In this …
The application of nanomedicine is expected to bring new hope to PDAC treatment. In this …
[PDF][PDF] Dendrimeric nanosystem consistently circumvents heterogeneous drug response and resistance in pancreatic cancer
J Liu, C Chen, T Wei, O Gayet, C Loncle, L Borge… - 2021 - arts.units.it
Pancreatic ductal adenocarcinoma (PDAC) is a deadly cancer with no efficacious treatment.
The application of nanomedicine is expected to bring new hope to PDAC treatment. In this …
The application of nanomedicine is expected to bring new hope to PDAC treatment. In this …